Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02173886 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery
A Phase 4 study, sponsored by North Dakota State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT02173886 is a Phase 4 study that has completed, run by North Dakota State University. The registered enrollment target is 20 participants.
The verdict
NCT02173886, a Phase 4 study, has completed, sponsored by North Dakota State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate how the body absorbs and processes the sustained release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are 1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled based on a matching criteria to post gastric bypass subjects. Participants will be asked to complete two 12-hour study days approximately 11 days apart.
Interventions
- DRUG Bupropion SR and XL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02173886
The ClinicalTrials.gov registry entry for NCT02173886 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Dakota State University, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupropion SR and XL is the first listed.
NCT02173886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02173886 about?
NCT02173886 is a clinical study titled "A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery". This study is being conducted to evaluate how the body absorbs and processes the sustained release (SR) and extended release (XL) medication bupropion (Wellbutrin®). Subject who are 1-3 years post gastric bypass surgery will be invited to participate. Non-surgical controls will also be enrolled base...
What is the current status of trial NCT02173886?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2014-06. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02173886?
The interventions under investigation include: Bupropion SR and XL (DRUG).
Who is sponsoring clinical trial NCT02173886?
This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.